111 Basic EPS 2018-2024 | YI
111 basic eps from 2018 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| 111 Annual Basic EPS | |
|---|---|
| 2024 | $-0.10 |
| 2023 | $-6.60 |
| 2022 | $-7.20 |
| 2021 | $-12.60 |
| 2020 | $-8.40 |
| 2019 | $-8.80 |
| 2018 | $-11.20 |
| 2017 | $-10.40 |
| 111 Quarterly Basic EPS | |
|---|---|
| 2024-09-30 | $-0.20 |
| 2024-06-30 | $-0.40 |
| 2024-03-31 | $-0.20 |
| 2023-12-31 | $-3.40 |
| 2023-09-30 | $-1.60 |
| 2023-06-30 | $-1.00 |
| 2023-03-31 | $-0.60 |
| 2022-12-31 | $-1.80 |
| 2022-09-30 | $-1.60 |
| 2022-06-30 | $-1.80 |
| 2022-03-31 | $-2.00 |
| 2021-12-31 | $-2.00 |
| 2021-09-30 | $-4.80 |
| 2021-06-30 | $-3.00 |
| 2021-03-31 | $-2.80 |
| 2020-12-31 | $-2.60 |
| 2020-09-30 | $-2.00 |
| 2020-06-30 | $-1.60 |
| 2020-03-31 | $-2.20 |
| 2019-12-31 | $-2.60 |
| 2019-09-30 | $-2.20 |
| 2019-06-30 | $-1.80 |
| 2019-03-31 | $-2.20 |
| 2018-09-30 | $-4.00 |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.072B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.687B | 52.05 |
| Tempus AI (TEM) | United States | $9.349B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
| Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
| IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
| Privia Health (PRVA) | United States | $2.840B | 212.82 |
| Enovis (ENOV) | United States | $1.994B | 12.34 |
| Schrodinger (SDGR) | United States | $1.883B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.471B | 31.72 |
| Phreesia (PHR) | United States | $1.461B | 0.00 |
| Azenta (AZTA) | United States | $1.216B | 56.62 |
| 10x Genomics (TXG) | United States | $1.025B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Talkspace (TALK) | United States | $0.532B | 316.00 |
| Veradigm (MDRX) | United States | $0.457B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.373B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Pulmonx (LUNG) | United States | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.31 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |